Advertisement
Health Topicsgenetic disorders-birth-defectsVirtual Journey: ATTR Amyloidosis

Virtual Journey: ATTR Amyloidosis

Living with and Treating ATTR Amyloidosis
Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
      Written by Jameson Kowalczyk. Medically reviewed in March 2025.

      Transthyretin amyloid cardiomyopathy is a condition that is caused by a buildup of abnormal protein deposits in the heart.

      Featured Content

      How does ATTR cardiomyopathy impact your quality of life?
      article

      How does ATTR cardiomyopathy impact your quality of life?

      Understanding quality of life and why it’s an important consideration when living with and treating ATTR-CM.
      ATTR cardiomyopathy: Gene silencers and gene stabilizers
      article

      ATTR cardiomyopathy: Gene silencers and gene stabilizers

      A look at two types of disease-modifying therapies used in the treatment of ATTR cardiomyopathy.
      ATTR-CM: Questions to ask when starting a new treatment
      article

      ATTR-CM: Questions to ask when starting a new treatment

      Questions to discuss with your healthcare provider when changing or adding therapies for ATTR-CM.
      How to seek support when living with ATTR cardiomyopathy
      article

      How to seek support when living with ATTR cardiomyopathy

      How ATTR cardiomyopathy may affect mental health and four strategies for seeking support.
      5 answers about ATTR amyloidosis
      article

      5 answers about ATTR amyloidosis

      How ATTR amyloidosis affects different organs, and what people with this condition need to know about treatment.